Bivalent second booster dose of the COVID-19 vaccine: Eligible populations' reasons for receiving in Italy

G Della Polla, G Miraglia del Giudice… - Human Vaccines & …, 2023 - Taylor & Francis
ABSTRACT The Italian Ministry of Health recommended the administration of the bivalent
second booster dose of the new available mRNA COVID-19 vaccine for subjects aged 60 y …

Investigating the reasons for receiving the second booster dose of the COVID-19 vaccine in adults and in people with chronic medical conditions in Southern Italy

G Miraglia del Giudice, L Folcarelli, G Della Polla… - Vaccines, 2023 - mdpi.com
This cross-sectional survey explored the attitudes and the reasons, as well their associated
factors, for receiving the second booster dose of the COVID-19 vaccine among a sample of …

[HTML][HTML] Relative effectiveness of a 2nd booster dose of COVID-19 mRNA vaccine up to four months post administration in individuals aged 80 years or more in Italy: A …

M Fabiani, A Mateo-Urdiales, C Sacco, MC Rota… - Vaccine, 2023 - Elsevier
Several countries started a 2nd booster COVID-19 vaccination campaign targeting the
elderly population, but evidence around its effectiveness is still scarce. This study aims to …

Intention to receive the COVID-19 vaccine booster dose in a university community in Italy

L Folcarelli, G Miraglia del Giudice, F Corea… - Vaccines, 2022 - mdpi.com
This cross-sectional study, conducted in Naples (Italy) between 16 November and 6
December 2021, explored the willingness to receive the booster dose of the COVID-19 …

Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly

C Mattiuzzi, G Lippi - Vaccines, 2023 - mdpi.com
Background: We analyzed coronavirus disease 2019 (COVID-19) vaccine efficacy in older
persons who received the second booster compared to unvaccinated people and those …

Willingness to accept a second COVID-19 vaccination booster dose among healthcare workers in Italy

G Della Polla, G Miraglia del Giudice… - Frontiers in Public …, 2022 - frontiersin.org
Background The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) is evolving, the newly emerged Omicron …

COVID-19 vaccines coverage and effectiveness against SARS-CoV-2 infection among residents in the largest Health Authority of Lazio region (Italy): a population …

V Fano, E Coviello, D Consonni, A Agresta… - Expert Review of …, 2022 - Taylor & Francis
Background The waning of the protective effect of COVID-19 vaccines and timing of booster
doses are debated. Methods Population-based cohort study in the largest Health-Authority …

COVID-19 Vaccination Effectiveness in the General Population of an Italian Province: Two Years of Follow-Up

A Rosso, ME Flacco, G Soldato, G Di Martino… - Vaccines, 2023 - mdpi.com
We carried out a cohort study on the overall population of the province of Pescara, Italy, to
assess the real-world effectiveness of SARS-CoV-2 vaccination against infection, severe, or …

[HTML][HTML] Role of the 1st booster dose of COVID-19 vaccine in the protection against the infection: A fundamental public health tool

S Calimeri, DL Giudice, A Buda, A Laganà… - Journal of Preventive …, 2022 - ncbi.nlm.nih.gov
Methods We conducted a retrospective sero-epidemiological survey of already existing data
concerning the antibody response of a HCWs sample vaccinated with the primary cycle and …

Significant increase in antibody titers after the 3rd booster dose of the Pfizer–BioNTech mRNA COVID-19 vaccine in healthcare workers in Greece

K Kontopoulou, CT Nakas, G Papazisis - Vaccines, 2022 - mdpi.com
The aim of our study was to assess the immunogenicity of the third dose of the BNT162b2
mRNA COVID-19 vaccine (Comirnaty) in a cohort of 129 health-care workers in Greece …